Cite Filings / PHAT / 0000950170-25-057326

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Phathom Pharmaceuticals, Inc. Filed 2025-04-23 Acc 0000950170-25-057326

Documents 1

DEF 14A Proxy Statement , phat-20250422.htm

Around this filing

2026-04-07 DEF 14A Proxy Statement
2025-04-24 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-04-23 ARS Annual Report to Security Holders
2025-04-23 DEFA14A Proxy Materials
2025-04-23 DEF 14A Proxy Statement
2025-04-16 4 Director acquired 21,000 shares (grant or award)
2024-04-12 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading phat-20250422.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…